Award,contract
Find a Tender
Complete
Save tender
NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026
Buyer: NHS England
Deadline
Not available — this notice may describe a possible future opportunity.
Region
Not specified
Value
£813,863,584
Type
Award,contract
SME fit
—
Duration
—
Description
NHS Branded Medicines Tranche B - Lot 1 - London & South of England - CM/PHR/25/5731 Period of Framework Agreement: 1 September 2026 to 31 August 2028 with an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Lot 2 - Ustekinumab for North of England and Midlands & East, period of Framework Agreement: 1st September 2026 to 31st August 2027 with an option or option(s) to extend for a further 12 months.
Awarded to
PFIZER LIMITED
£813,863,584
Abbvie Ltd
£813,863,584
ACCORD-UK LTD
£813,863,584
AMGEN LIMITED
£18,903,212
BIOGEN IDEC LIMITED
£18,903,212
DR REDDY'S LABORATORIES (UK) LIMITED
£813,863,584
Fresenius Kabi Limited
£18,903,212
GEDEON RICHTER (UK) LIMITED
£18,903,212
ROCHE PRODUCTS LIMITED
£813,863,584
GLAXOSMITHKLINE UK LIMITED
£813,863,584
JANSSEN-CILAG LIMITED
£18,903,212
MILPHARM LIMITED
£813,863,584
ORGANON PHARMA (UK) LIMITED
£813,863,584
ORIFARM UK LTD
£813,863,584
SAMSUNG BIOEPIS UK LIMITED
£813,863,584
SANDOZ LIMITED
£18,903,212
SWEDISH ORPHAN BIOVITRUM LTD
£813,863,584
Teva UK Limited
£813,863,584
THORNTON & ROSS LIMITED
£18,903,212
UCB PHARMA LIMITED
£813,863,584
ZENTIVA PHARMA UK LIMITED
£813,863,584
Celltrion Healthcare United Kingdom Limited
£18,903,212
AVENTIS PHARMA LIMITED
£813,863,584
Quick actions
Key details
- CPV category
- —
- Procurement method
- Open procedure
- Published
- 09 Jun 2026 10:09
- VCSE suitable
- —
Reference
- OCID
- ocds-h6vhtk-051a9d
- Notice ID
- C414011
- In our database since
- 17 Aug 2026